AI Trial Targets Faster Breast Cancer Diagnoses for 700,000 Women in the UK
The £11 million EDITH trial will use AI to assist radiologists, aiming to reduce delays and improve early detection through a nationwide pilot at 30 NHS sites.
- The EDITH trial, backed by £11 million in funding, will test AI-assisted mammogram analysis for nearly 700,000 women aged 50-70 across 30 NHS sites in the UK.
- AI technology will replace one of the two radiologists traditionally required to analyze scans, addressing a national shortage of radiologists and reducing diagnostic delays.
- Health officials and experts believe the trial could accelerate early detection of breast cancer, improve patient outcomes, and alleviate pressure on NHS resources.
- The trial is part of a broader effort to combat long-standing issues in cancer care, with a national cancer plan set to be unveiled later this year to enhance diagnosis and treatment.
- While the potential of AI is widely acknowledged, experts caution that its adoption must include rigorous oversight and patient trust to ensure safety and effectiveness.
The Guardian 
The Independent 
The Times 
Sky News 
Open Access Government 
The Telegraph 